Dominique Besson
Overview
Explore the profile of Dominique Besson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adam A, Besson D, Bryant R, Rees S, Willis P, Burrows J, et al.
ACS Infect Dis
. 2024 Nov;
10(12):4030-4039.
PMID: 39488746
The coronavirus pandemic outbreak of 2019 highlighted the critical importance of preparedness for current and future public health threats (https://www.mmv.org/mmv-open/global-health-priority-box/about-global-health-priority-box). While the main attention for the past few years has...
2.
Oudard S, Tran Y, Helissey C, Vauchier C, Ratta R, Bennamoun M, et al.
Eur Urol Oncol
. 2024 Aug;
8(1):126-134.
PMID: 39143002
Background And Objective: The CABASTY study showed that more frequent administration of a lower dose of cabazitaxel (CBZ) reduced toxicity in older men with metastatic castration-resistant prostate cancer (mCRPC), without...
3.
Adam A, Chenu E, Besson D
SLAS Discov
. 2024 Jun;
29(5):100168.
PMID: 38866329
Despite the efforts towards malaria eradication, latest estimates show that the number of malaria cases is still rising, and malaria continues to have a devastating impact on people's health and...
4.
Bosc N, Felix E, Gardner J, Mills J, Timmerman M, Asveld D, et al.
ACS Med Chem Lett
. 2023 Dec;
14(12):1733-1741.
PMID: 38116432
Efforts to tackle malaria must continue for a disease that threatens half of the global population. Parasite resistance to current therapies requires new chemotypes that are able to demonstrate effectiveness...
5.
Oudard S, Ratta R, Voog E, Barthelemy P, Thiery-Vuillemin A, Bennamoun M, et al.
JAMA Oncol
. 2023 Oct;
9(12):1629-1638.
PMID: 37883073
Importance: Many patients 65 years or older with metastatic castration-resistant prostate cancer (mCRPC) are denied taxane chemotherapy because this treatment is considered unsuitable. Objective: To determine whether biweekly cabazitaxel (CBZ),...
6.
Walz A, Duffey M, Aljayyoussi G, Sax S, Leroy D, Besson D, et al.
Pharmaceuticals (Basel)
. 2023 Apr;
16(2).
PMID: 37009844
With artemisinin-resistant parasites emerging in Africa, the need for new antimalarial chemotypes is persistently high. The ideal pharmacodynamic parameters of a candidate drug are a rapid onset of action and...
7.
Samby K, Besson D, Dutta A, Patra B, Doy A, Glossop P, et al.
ACS Infect Dis
. 2022 Mar;
8(4):713-720.
PMID: 35286809
The current Covid-19 pandemic has underlined the need for a more coordinated and forward-looking investment in the search for new medicines targeting emerging health care threats. Repositioning currently approved drugs...
8.
Pujalte Martin M, Borchiellini D, Thamphya B, Guillot A, Paoli J, Besson D, et al.
Clin Genitourin Cancer
. 2021 Oct;
19(6):501-509.
PMID: 34629300
Background: Docetaxel (DOCE) is a standard of care in metastatic castration-resistant prostate cancer (mCRPC). Several retrospective studies suggested a decrease in Prostate Cancer incidence and mortality with metformin (MET). MET...
9.
Metges J, Douillard J, Ramee J, Dupuis O, Senellart H, Porneuf M, et al.
Turk J Gastroenterol
. 2020 Nov;
31(10):695-705.
PMID: 33169707
Background/aims: The Bretagne-Pays de la Loire cancer observatory, an oncology network created by the French Ministry of Health, is specifically dedicated to assess the use of new targeted anticancer therapies...
10.
Molette J, Routier J, Abla N, Besson D, Bombrun A, Brun R, et al.
ACS Med Chem Lett
. 2014 Jun;
4(11):1037-41.
PMID: 24900603
Recent observations on the emergence of artemisinin resistant parasites have highlighted the need for new antimalarial treatments. An HTS campaign led to the identification of the 1-(1-aminopropan-2-ol)carbazole analogues as potent...